Cover Image

EARLY ONSET SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN AN ELDERLY WOMAN

ROSELYNN MAREENA RACHEL S, JESSIE LIONEL

Abstract


Ovulatory dysfunction accounts for 30-40 of   female infertility and ovulation induction is one of the main ways of treating it. It has become a safe and commonly used approach to infertility. But undesired side effects still exist .It may result in a supra physiological response that leads to an iatrogenic , potentially lethal condition called Ovarian Hyper stimulation Syndrome (OHSS). The following is a case report of a 42 year old lady who developed early onset severe OHSS.

 


Full Text:

PDF

References


J. G. Whelan and N. F. Vlahos, “The ovarian hyperstimulation syndrome,” Fertil. Steril., vol. 73, no. 5, pp. 883–896, May 2000.

P. Humaidan, J. Quartarolo, and E. G. Papanikolaou, “Preventing ovarian hyperstimulation syndrome: guidance for the clinician,” Fertil. Steril., vol. 94, no. 2, pp. 389–400, Jul. 2010.

D. Navot, P. A. Bergh, and N. Laufer, “Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment,” Fertil. Steril., vol. 58, no. 2, pp. 249–261, Aug. 1992.

P. R. Brinsden, I. Wada, S. L. Tan, A. Balen, and H. S. Jacobs, “Diagnosis, prevention and management of ovarian hyperstimulation syndrome,” Br. J. Obstet. Gynaecol., vol. 102, no. 10, pp. 767–772, Oct. 1995.

K. Fiedler and D. Ezcurra, “Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment,” Reprod. Biol. Endocrinol. RBE, vol. 10, p. 32, 2012.

E. G. Papanikolaou, P. Humaidan, N. P. Polyzos, and B. Tarlatzis, “Identification of the highrisk patient for ovarian hyperstimulation syndrome,” Semin. Reprod. Med., vol. 28, no. 6, pp. 458–462, Nov. 2010.

M. A. F. M. Youssef, M. van Wely, M. A. Hassan, H. G. Al-Inany, M. Mochtar, S. Khattab, and F. van der Veen, “Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis,” Hum. Reprod. Update, vol. 16, no. 5, pp. 459–466, Oct. 2010.

L. Herrero, M. Martínez, and J. A. Garcia-Velasco, “Current status of human oocyte and embryo cryopreservation,” Curr. Opin. Obstet. Gynecol., vol. 23, no. 4, pp. 245–250, Aug. 2011.

M. Aboulghar, “Treatment of ovarian hyperstimulation syndrome,” Semin. Reprod. Med., vol. 28, no. 6, pp. 532–539, Nov. 2010.

M. A. Aboulghar, R. T. Mansour, G. I. Serour, and Y. Amin, “Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome,” Fertil. Steril., vol. 53, no. 5, pp. 933–935, May 1990.

D. H. Beck, S. Massey, B. L. Taylor, and G. B. Smith, “Continuous ascitic recirculation in severe ovarian hyperstimulation syndrome,” Intensive Care Med., vol. 21, no. 7, pp. 590–593, Jul. 1995.

M. H. Aurousseau, M. M. Samama, A. Belhassen, F. Herve, and J. N. Hugues, “Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports,” Hum. Reprod. Oxf. Engl., vol. 10, no. 1, pp. 94–97, Jan. 1995.

C. D. Chen, M. Y. Wu, J. H. Yang, S. U. Chen, H. N. Ho, and Y. S. Yang, “Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome,” Fertil. Steril., vol. 68, no. 2, pp. 287–291, Aug. 1997.

Z. O. Amarin, “Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome. An aggressive, but perhaps life-saving procedure,” Hum. Reprod. Oxf. Engl., vol. 18, no. 4, pp. 659–664, Apr. 2003.

T. Tsunoda, H. Shibahara, Y. Hirano, T. Suzuki, H. Fujiwara, S. Takamizawa, S. Ogawa, M. Motoyama, and M. Suzuki, “Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine,” Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol., vol. 17, no. 4, pp. 281–286, Aug. 2003.

A. Torabizadeh, F. Vahidroodsari, and Z. Ghorbanpour, “Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study,” Iran. J. Reprod. Med., vol. 11, no. 10, pp. 837–842, Oct. 2013.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University